Ex vivo evaluation of a new neonatal/infant oxygenator: Comparison of the Terumo CAPIOX® Baby RX with Dideco Lilliput 1 and Polystan Safe Micro in the piglet model

Perfusion

Volumn 19, Issue 5, 2004, Pages 315-321

  Dubois, J ^a   Jamaer, L ^a   Mess, U ^a   Pauwels, J L ^a   Briers, F ^a   Lehaen, J ^a   Hendrikx, Marc ^a,b  

^a VIRGA JESSE HOSPITAL   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; OXYGEN; POLYMER; THROMBIN ANTITHROMBIN COMPLEX;

ARTERIAL BLOOD; ARTICLE; BIOCOMPATIBILITY; BLOOD CELL COUNT; BLOOD GAS ANALYSIS; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; COOLING; EX VIVO STUDY; GAS FLOW; HEART SURGERY; HEMOGLOBIN DETERMINATION; HEMOLYSIS; INTERMETHOD COMPARISON; LOW TEMPERATURE PROCEDURES; NONHUMAN; OXYGEN TRANSPORT; OXYGENATOR; PRESSURE MEASUREMENT; PRIORITY JOURNAL; RECORDING; STANDARDIZATION; TEMPERATURE MEASUREMENT; VENOUS BLOOD;

ANIMALS; BLOOD GAS ANALYSIS; CARDIOPULMONARY BYPASS; HEMOGLOBINS; HEMOLYSIS; HUMANS; INFANT; INFANT, NEWBORN; OXYGENATORS; PRESSURE; SWINE; TIME FACTORS;

EID: 5444240838     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1191/0267659104pf758oa     Document Type: Article

References (16)

1. Nagy ZL, Collins M, Sharpe T et al. Effect of two different bypass techniques on the serum troponin-T levels in newborns and children: does pH-Stat provide better protection? Circulation 2003; 108: 577-82.
2. Davies LK. Cardiopulmonary bypass in infants and children: how is it different? J Cardiothorac Vasc Anesth 1999; 13: 330-45.
3. Cooper MM, Elliot M. Haemodilution. In Jonas RA, Elliot M eds. Cardiopulmonary bypass in neonates, infants and young children. Oxford: Butterworth-Heinemann, 1994: 82-100.
4. Gaynor JW. The effect of modified ultrafiltration on the postoperative course in patients with congenital heart disease. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2003; 6: 128-39.
5. Wang W, Huang HM, Zhu DM, Chen H, So ZK, Ding WX. Modified ultrafiltration in paediatric cardiopulmonary bypass. Perfusion 1998; 13: 304-10.
6. Allen ML, Peters MJ, Goldman A et al. Early post-operative monocyte deactivation predicts systemic inflammation and prolonged stay in pediatric cardiac intensive care. Crit Care Med 2002; 30: 1140-45.
7. Tinius JA, Dragomer D, Klutka F, VanBebber A, Cerney K. The Capiox RX05 oxygenator: pediatric clinical observations. Perfusion 2003; 18: 321-23.
8. Fischer AR. The incidence and cause of emergency oxygenator changeovers. Perfusion 1999; 14: 207-12.
9. Schaadt J. Oxygenator thrombosis: an international phenomenon. Perfusion 1999; 14: 425-35.
10. Palanzo DA, Zarro DL, Montesano RM et al. Effect of trillium biopassive surface coating of the oxygenator on platelet count drop during cardiopulmonary bypass. Perfusion 1999; 14: 473-79.
11. Noora J, Lamy A, Smith KM et al. The effect of oxygenator membranes on blood: a comparison of two oxygenators in open-heart surgery. Perfusion 2003; 18: 313-20.
12. Hennessy VL Jr, Hicks RE, Niewiarowski S, Edmunds LH Jr, Colman RW. Function of human platelets during extracorporeal circulation. Am J Physiol 1977; 232: H622-28.
13. 1 during in vitro simulation of cardiopulmonary bypass. Circ Res 1979; 44: 350-57.
14. Bearss MG, Ericson D, Parks PJ, Rice R. The puzzling case of the cryoprecipitates. AMSECT Today 1996; June: 21-25.
15. Usui A, Hiroura M, Kawamura M. Heparin coating extends the durability of oxygenators used for cardiopulmonary support. Artif Organs 1999; 23: 840-44.
16. Gaylor JDS, Hickey S, Bell G, Pei JM. Membrane oxygenators: influence of design on performance. Perfusion 1994; 9: 173-80.